Expression of fractalkine and fractalkine receptor in urinary bladder after cyclophosphamide (CYP)-induced cystitis

Autonomic Neuroscience: Basic and Clinical

Volumn 126-127, Issue , 2006, Pages 380-389

  Yuridullah, Ruhin ^a   Corrow, Kimberly A ^a   Malley, Susan E ^a   Vizzard, Margaret A ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Chemokines; ELISA; Inflammation; Urothelium; Western blot

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; CYCLOPHOSPHAMIDE; FRACTALKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; CONTROLLED STUDY; CORONARY BLOOD VESSEL; CYSTITIS; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; MICTURITION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR UPREGULATION; UROTHELIUM; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; CHEMOKINES, CX3C; CYCLOPHOSPHAMIDE; CYSTITIS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; RATS; RATS, WISTAR; RECEPTORS, CYTOKINE; RECEPTORS, HIV; TIME FACTORS; UBIQUITIN THIOLESTERASE; URINARY BLADDER;

EID: 33744544014     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2006.02.030     Document Type: Article

References (53)

1. Ahn S.Y., Cho C.H., Park K.G., Lee H.J., Lee S., Park S.K., Lee I.K., and Koh G.Y. Tumor necrosis factor-alpha induces fractalkine expression preferentially in arterial endothelial cells and mithramycin A suppresses TNF-alpha-induced fractalkine expression. Am. J. Pathol. 164 (2004) 1663-1672
2. Baba H., Doubell T.P., and Woolf C.J. Peripheral inflammation facilitates A beta fiber-mediated synaptic input to the substantia gelatinosa of the adult rat spinal cord. J. Neurosci. 19 (1999) 859-867
3. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., and Schall T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature 385 (1997) 640-644
4. Birder L.A. More than just a barrier: urothelium as a drug target for urinary bladder pain. Am. J. Physiol.: Renal. Physiol. 289 (2005) F489-F495
5. Birder L.A. Role of the urothelium in urinary bladder dysfunction following spinal cord injury. Prog. Brain Res. 152 (2005) 135-146
6. Birder L.A., Kanai A.J., deGroat W.C., Kiss S., Nealen M.L., Burke N.E., Dineley K.E., Watkins S., Reynolds I.J., and Caterina M.J. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 13396-13401
7. Braas K.M., May V., Zvara P., Nausch B., Kliment J., Dunleavy J.D., and Nelson M.T. Role for pituitary adenylate cyclase activating polypeptide (PACAP) in cystitis-induced plasticity of micturition reflexes. Regul. Pept. 130 (2005) 157
8. Chancellor M.B., and Yoshimura N. Treatment of interstitial cystitis. Urology 63 (2004) 85-92
9. Dattilio A., and Vizzard M.A. Up-regulation of protease activated receptors in bladder after cyclophosphamide induced cystitis and colocalization with capsaicin receptor (VR1) in bladder nerve fibers. J. Urol. 173 (2005) 635-639
10. Dinarello C.A.D. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest 112 (1997) 321S-329S
11. Dinarello C.A. Overview of inflammatory cytokines and their role in pain. In: Watkins L.R., and Maier S.F. (Eds). Cytokines and Pain (1998), Birkhauser Verlag, Boston 1-20
12. Dray A. Inflammatory mediators of pain. Br. J. Anaesth. 75 (1995) 125-131
13. Driscoll A., and Teichman J.M.H. How do patients with interstitial cystitis present?. J. Urol. 166 (2001) 2118-2120
14. Dupont M.C., Spitsbergen J.M., Kim K.B., Tuttle J.B., and Steers W.D. Histological and neurotrophic changes triggered by varying models of bladder inflammation. J. Urol. 166 (2001) 1111-1118
15. Fong A.M., Robinson L.A., Steeber D.A., Tedder T.F., Yoshie O., Imai T., and Patel D.D. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188 (1998) 1413-1419
16. Garcia G.E., Xia Y., Chen S., Wang Y., Ye R.D., Harrison J.K., Bacon K.B., Zerwes H.G., and Feng L. NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS. J. Leukoc. Biol. 67 (2000) 577-584
17. Haskell C.A., Cleary M.D., and Charo I.F. Unique role of the chemokine domain of fractalkine in cell capture. Kinetics of receptor dissociation correlate with cell adhesion. J. Biol. Chem. 275 (2000) 34183-34189
18. Ho N., Koziol J.A., and Parsons C.L. Epidemiology of interstitial cystitis. In: Sant G.R. (Ed). Interstitial Cystitis (1997), Lippincott-Raven Publishers, Philadelphia 9-16
19. Hu V.Y., Malley S., Dattilio A., Folsom J.B., Zvara P., and Vizzard M.A. COX-2 and prostanoid expression in micturition pathways after cyclophosphamide-induced cystitis in the rat. Am. J. Physiol., Regul. Integr. Comp. 284 (2003) R574-R585
20. Hughes P.M., Botham M.S., Frentzel S., Mir A., and Perry V.H. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37 (2002) 314-327
21. Johansson S.L., Ogawa K., and Fall M. The pathology of interstitial cystitis. In: Sant G.R. (Ed). Interstitial Cystitis (1997), Lippincott-Raven Publishers, Philadelphia 143-152
22. Johnston I.N., Milligan E.D., Wieseler-Frank J., Frank M.G., Zapata V., Campisi J., Langer S., Martin D., Green P., Fleshner M., Leinwand L., Maier S.F., and Watkins L.R. A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine. J. Neurosci. 24 (2004) 7353-7365
23. Lindia J.A., McGowan E., Jochnowitz N., and Abbadie C. Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J. Pain 6 (2005) 434-438
24. Lindsay R.M., and Harmar A.J. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 337 (1989) 362-367
25. Malley S.E., and Vizzard M.A. Changes in urinary bladder cytokine mRNA and protein after cyclophosphamide-induced cystitis. Physiol. Genomics 9 (2002) 5-13
26. Marchand F., Perretti M., and McMahon S.B. Role of the immune system in chronic pain. Nat. Rev., Neurosci. 6 (2005) 521-532
27. Mason J.L., Suzuki K., Chaplin D.D., and Matsushima G.K. Interleukin-1 beta promotes repair of the CNS. J. Neurosci. 21 (2001) 7046-7052
28. Milligan E.D., Zapata V., Chacur M., Schoeniger D., Biedenkapp J., O'Connor K.A., Verge G.M., Chapman G., Green P., Foster A.C., Naeve G.S., Maier S.F., and Watkins L.R. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur. J. Neurosci. 20 (2004) 2294-2302
29. Murray E., Malley S.E., Qiao L.Y., Hu V.Y., and Vizzard M.A. Cyclophosphamide induced cystitis alters neurotrophin and receptor tyrosine kinase expression in pelvic Ganglia and bladder. J. Urol. 172 (2004) 2434-2439
30. Nagarsekar A., Hasday J.D., and Singh I.S. CXC chemokines: a new family of heat-shock proteins?. Immunol. Invest. 34 (2005) 381-398
31. Petrone R.L., Agha A.H., Roy J.B., and Hurst R.E. Urodynamic findings in patients with interstitial cystitis. J. Urol. 153 (1995) 290A
32. Raychaudhuri S., Jiang W.-Y., and Farber E. Cellular localization of fractalkine at sites of inflammation: antigen-presenting cells in psoriasis express high levels of fractalkine. Br. J. Dermatol. (2001) 1105-1113
33. Sant G., and Hanno P.M. Interstitial cystitis: current issues and controversies in diagnosis. Urology 57 (2001) 82
34. Steers W.D., and de Groat W.C. Effect of bladder outlet obstruction on micturition reflex pathways in the rat. J. Urol. 140 (1988) 864-871
35. Steers W.D., Kolbeck S., Creedon D., and Tuttle J.B. Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. J. Clin. Invest. 88 (1991) 1709-1715
36. Steers W.D., Ciambotti J., Etzel B., Erdman S., and de Groat W.C. Alterations in afferent pathways from the urinary bladder of the rat in response to partial urethral obstruction. J. Comp. Neurol. 310 (1991) 1-10
37. Steers W.D., Creedon D.J., and Tuttle J.B. Immunity to nerve growth factor prevents afferent plasticity following urinary bladder hypertrophy. J. Urol. 155 (1996) 379-385
38. Sung M.J., Kim W., Ahn S.Y., Cho C.H., Koh G.Y., Moon S.O., Hoon Kim D., Lee S., Kang K.P., Jang K.Y., and Park S.K. Protective effect of {alpha}-lipoic acid in lipopolysaccharide-induced endothelial fractalkine expression. Circ. Res. 97 9 (2005) 880-890
39. Tuttle J.B., Mackey T., and Steers W.D. NGF, bFGF and CNTF increase survival of major pelvic ganglion neurons cultured from the adult rat. Neurosci. Lett. 173 (1994) 94-98
40. Tuttle J.B., Steers W.D., Albo M., and Nataluk E. Neural input regulates tissue NGF and growth of the adult rat urinary bladder. J. Auton. Nerv. Syst. 49 (1994) 147-158
41. Verge G.M., Milligan E.D., Maier S.F., Watkins L.R., Naeve G.S., and Foster A.C. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur. J. Neurosci. 20 (2004) 1150-1160
42. Vizzard M.A. Increased expression of neuronal nitric oxide synthase in bladder afferent and spinal neurons following spinal cord injury. Dev. Neurosci. 19 3 (1997) 232-246
43. Vizzard M.A. Changes in urinary bladder neurotrophic factor mRNA and NGF protein following urinary bladder dysfunction. Exp. Neurol. 161 (2000) 273-284
44. Vizzard M.A. Up-regulation of pituitary adenylate cyclase-activating polypeptide in urinary bladder pathways after chronic cystitis. J. Comp. Neurol. 420 (2000) 335-348
45. Vizzard M.A. Alterations in neuropeptide expression in lumbosacral bladder pathways following chronic cystitis. J. Chem. Neuroanat. 21 (2001) 125-138
46. Vizzard M.A., and Boyle M.M. Increased expression of growth-associated protein (GAP-43) in lower urinary tract pathways following cyclophosphamide (CYP)-induced cystitis. Brain Res. 844 (1999) 174-187
47. Watkins L.R., and Maier S.F. Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. Physiol. Rev. 82 (2002) 981-1011
48. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci. 24 (2001) 450-455
49. Watkins L.R., Hutchinson M.R., Johnston I.N., and Maier S.F. Glia: novel counterregulators of opioid analgesia. Trends Neurosci. 28 12 (2005) 661-669
50. Wieseler-Frank J., Maier S.F., and Watkins L.R. Glial activation and pathological pain. Neurochem. Int. 45 (2004) 389-395
51. Yamashita K., Imaizumi T., Hatakeyama M., Tamo W., Kimura D., Kumagai M., Yoshida H., and Satoh K. Effect of hypoxia on the expression of fractalkine in human endothelial cells. Tohoku J. Exp. Med. 200 (2003) 187-194
52. Yoshimura N., and de Groat W.C. Increased excitability of afferent neurons innervating rat urinary bladder following chronic bladder inflammation. J. Neurosci. 19 (1999) 4644-4653
53. Zvarova K., and Vizzard M.A. Distribution and fate of cocaine- and amphetamine-regulated transcript peptide (CARTp)-expressing cells in rat urinary bladder: a developmental study. J. Comp. Neurol. 489 (2005) 501-517